Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug 30;44(1):103.
doi: 10.1186/s13052-018-0529-2.

Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks

Alessandra Marchesi  1 , Isabella Tarissi de Jacobis  2 , Donato Rigante  3 , Alessandro Rimini  4 , Walter Malorni  5 , Giovanni Corsello  6 , Grazia Bossi  7 , Sabrina Buonuomo  2 , Fabio Cardinale  8 , Elisabetta Cortis  9 , Fabrizio De Benedetti  2 , Andrea De Zorzi  2 , Marzia Duse  10 , Domenico Del Principe  11 , Rosa Maria Dellepiane  12 , Livio D'Isanto  13 , Maya El Hachem  2 , Susanna Esposito  14 , Fernanda Falcini  15 , Ugo Giordano  2 , Maria Cristina Maggio  6 , Savina Mannarino  7 , Gianluigi Marseglia  7 , Silvana Martino  16 , Giulia Marucci  2 , Rossella Massaro  17 , Christian Pescosolido  17 , Donatella Pietraforte  5 , Maria Cristina Pietrogrande  12 , Patrizia Salice  12 , Aurelio Secinaro  2 , Elisabetta Straface  5 , Alberto Villani  2
Affiliations
Review

Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks

Alessandra Marchesi et al. Ital J Pediatr. .

Abstract

This second part of practical Guidelines related to Kawasaki disease (KD) has the goal of contributing to prompt diagnosis and most appropriate treatment of KD resistant forms and cardiovascular complications, including non-pharmacologic treatments, follow-up, lifestyle and prevention of cardiovascular risks in the long-term through a set of 17 recommendations.Guidelines, however, should not be considered a norm that limits the treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or individual complications.

Keywords: Aspirin; Child; Coronary artery abnormalities; Innovative biotechnologies; Intravenous immunoglobulin; Kawasaki disease; Personalized medicine.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Treatment of low-risk KD patients
Fig. 2
Fig. 2
Treatment of high-risk KD patients
See this image and copyright information in PMC

References

    1. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term Management of Kawasaki Disease, a scientific statement for health professionals from the American heart. Circulation. 2017;135:e927–e999. doi: 10.1161/CIR.0000000000000484. - DOI - PubMed
    1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11. doi: 10.1002/art.37715. - DOI - PubMed
    1. Esposito S, Rigante D, Principi N. The role of infection in Kawasaki syndrome. J Infect. 2013;67:1–10. doi: 10.1016/j.jinf.2013.04.004. - DOI - PMC - PubMed
    1. Rigante D, Tarantino G, Valentini P. Non-infectious makers of Kawasaki syndrome: tangible or elusive triggers? Immunol Res. 2016;64:51–54. doi: 10.1007/s12026-015-8679-4. - DOI - PubMed
    1. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation. 1993;87:1776–1780. doi: 10.1161/01.CIR.87.5.1776. - DOI - PubMed

MeSH terms

Substances